Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
WW International acquisition has announced plans to prepay and reduce debt at WW International, a healthcare services other business in New York, for up to $40 million. WW International operates science-backed weight management programs and an integrated weight health ecosystem that combines coaching, technology, and clinical interventions for subscribers and corporate offerings. The company’s healthcare services other platform supports weight-loss outcomes and access to GLP-1 medications when clinically appropriate, aligning with liquidity and deleveraging goals in NY acquisitions. The other acquisition is structured as a term loan cash sweep plus a voluntary discounted prepayment solicitation, with $25 million to $30 million expected June 24, 2026 and up to $10 million solicited April 27–April 30, 2026, as part of healthcare M&A focused on strengthening capital structure.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026